Distinguished in Transient Ischemic Attack (TIA)

Gotz J. Thomalla

Hamburg, HH, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Transient Ischemic Attack (TIA)
Hamburg, HH, DE 
OverviewLocationsClinical Research

Overview

Gotz Thomalla practices in Hamburg, Germany. Thomalla is rated as a Distinguished expert by MediFind in the treatment of Transient Ischemic Attack (TIA). Their top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Carotid Artery Disease, Thrombectomy, and Stent Placement.

Their clinical research consists of co-authoring 472 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 20 articles and participated in 2 clinical trials in the study of Transient Ischemic Attack (TIA).

Locations

Hamburg, HH, Germany
Other Locations
Berlin, BE, Germany
Eppendorf, HH 20246, Germany
Munich, BY, Germany
Charité Universitätsmedizin Berlin And Neurologie Der Rehaklinik Medical Park Humboldtmühle, Campus Lübeck, Luebeck, SH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Recruiting
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Enrollment Status: Completed
Publish Date: March 26, 2025
Intervention Type: Diagnostic test
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke
Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke
Enrollment Status: Completed
Publish Date: September 13, 2023
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Enrollment Status: Completed
Publish Date: January 28, 2021
Intervention Type: Drug
Study Phase: Phase 2
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

472 Total Publications

Periodontal Health and Outcome of Atherosclerotic Disease in the Hamburg City Health Study.
Periodontal Health and Outcome of Atherosclerotic Disease in the Hamburg City Health Study.
Journal: Journal of dental research
Published: October 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Thomalla's expertise for a condition
ConditionClose
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile